Fulgent Genetics Stock Investor Sentiment
| FLGT Stock | USD 18.07 0.18 1.01% |
Slightly above 53% of Fulgent Genetics' investor base is interested to short. The analysis of overall sentiment of trading Fulgent Genetics stock suggests that many investors are impartial at this time. Fulgent Genetics' investing sentiment can be driven by a variety of factors including economic data, Fulgent Genetics' earnings reports, geopolitical events, and overall market trends.
Fulgent |
Fulgent Genetics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Fulgent Genetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Fulgent Genetics that are available to investors today. That information is available publicly through Fulgent media outlets and privately through word of mouth or via Fulgent internal channels. However, regardless of the origin, that massive amount of Fulgent data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fulgent Genetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fulgent Genetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fulgent Genetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fulgent Genetics alpha.
Fulgent Genetics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Gao Hanlin of 27 shares of Fulgent Genetics subject to Rule 16b-3 | 10/14/2024 |
2 | Disposition of 4345 shares by Jian Xie of Fulgent Genetics at 19.42 subject to Rule 16b-3 | 10/25/2024 |
3 | Disposition of tradable shares by Gao Hanlin of Fulgent Genetics at 20.27 subject to Rule 16b-3 | 10/30/2024 |
4 | Positive week for Fulgent Genetics, Inc. institutional investors who lost 20 percent over the past year | 11/01/2024 |
5 | Fulgent Genetics Q3 2024 Earnings Preview | 11/07/2024 |
6 | Fulgent Genetics Non-GAAP EPS of 0.31 beats by 0.46, revenue of 71.7M in-line | 11/08/2024 |
7 | Fulgent Genetics Downgraded to Sell Rating by StockNews.com | 11/12/2024 |
8 | Fulgent Genetics Hits New 52-Week Low Heres What Happened | 11/19/2024 |
9 | Fulgent Genetics, Inc. Among the Best Genomics Stocks to Buy Right Now | 11/20/2024 |
10 | Gene Panel Market to Surpass USD 11.75 Billion by 2031 SkyQuest Technology | 11/22/2024 |
11 | Disposition of 689 shares by Jian Xie of Fulgent Genetics at 18.2593 subject to Rule 16b-3 | 11/25/2024 |
12 | Fulgent Genetics CEO Ming Hsieh sells 40,663 in stock | 11/27/2024 |
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.